Valantine Hannah bought BBIO

June 22, 2026 · Form 4 insider transaction

Valantine Hannah bought 2,808 shares of BridgeBio Pharma, Inc. at $41.73 per share, a transaction worth $117.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.